Followers | 63 |
Posts | 8502 |
Boards Moderated | 0 |
Alias Born | 01/10/2014 |
Monday, August 13, 2018 4:20:02 PM
How many shares of the Company’s stock are currently outstanding?
As of August 12, 2018, the Company had 4,447,676,982 share of its common stock issued and outstanding, of which (i) 1,606,347,924 shares were restricted; and, (ii) 2,841,329,058 were free-trading. As of August 12, 2018, the Company had 1,000,000 shares of its Series A Preferred Stock issue and outstanding.
Why is the shell risk flag still on OTC Markets listing?
You should recall that the Company was previously considered to be a “shell” (a company which has (i) no or nominal operations; and, (ii) no or nominal assets (or, assets consisting mostly of cash). When the Company ceased to be a shell in January, 2018, the designation as a “shell” was removed by OTC Markets. However, it is the policy of OTC Markets to place a ‘shell risk” flag on companies for a period of time after they cease being a shell. We expect that the shell risk flag will be removed by the end of the year.
What is status of the long-term debt which has been on the Company’s books?
The $125,000 convertible note was reassigned in a private transaction between the existing noteholder and another organization that has had no previous interactions with the Company or Mr. Remillard. The current noteholder has communicated its intent to be supportive of the Company, and expressed its approval of our plan to be a major power in the global cyber data security marketplace.
Statements made are only my opinion. Do your own DD in order to make your Investment decisions.
Recent ATDS News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/29/2023 09:25:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:13:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 09:27:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 09:18:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 09:17:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM